Posted by Michael Wonder on 26 Sep 2023
Ultragenyx launches Evkeeza (evinacumab for injection) in Canada for the treatment of homozygous familial hypercholesterolaemia
25 September 2023 - Evkeeza is a first in class medicine approved by Health Canada, the US FDA and European Commission to treat an ultra-rare, inherited form of high cholesterol.
Ultragenyx Pharmaceutical today announced the approval of Evkeeza (evinacumab) in Canada.
